Sridharan Gururangan

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme

James J. Vredenburgh, Annick Desjardins, James E. Herndon et al. · Journal of Clinical Oncology · 2007 · 1.4K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma

James J. Vredenburgh, Annick Desjardins, James E. Herndon et al. · Clinical Cancer Research · 2007 · 1.1K citations · Full text

Medicine, Oncology, Pharmacology +17

Novel mutations target distinct subgroups of medulloblastoma

Giles Robinson, Matthew Parker, Tanya A. Kranenburg et al. · Nature · 2012 · 853 citations · Full text

Medicine, Genetics, Oncology +17

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog–Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032

Giles Robinson, Brent A. Orr, Gang Wu et al. · Journal of Clinical Oncology · 2015 · 460 citations · Full text

Medicine, Oncology, Pharmacology +15

Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis

Vijay Ramaswamy, Marc Remke, Éric Bouffet et al. · The Lancet Oncology · 2013 · 404 citations · Full text

Medicine, Cancer Biology, Oncology +16